ATF4 and cancer: In cancer cells, DT-061 treatment drives specific t-RNA charging signaling pathways to bias the translational machinery toward activating oxidative stress and ISR genes, such as ATF4, CHOP, DR5, and TRIB3, ultimately leading to an increase in autophagy, necroptosis, and apoptosis triggered by chronic and irreversible ISR.